- Tytuł:
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
- Autorzy:
- Źródło:
- Lancet. 11/4/2017, Vol. 390 Issue 10107, p2063-2072. 10p.
Czasopismo naukowe